Literature DB >> 26948886

Treatment of Severe Alcoholic Hepatitis.

Mark Thursz1, Timothy R Morgan2.   

Abstract

Alcoholic hepatitis (AH) is a syndrome of jaundice and liver failure that occurs in a minority of heavy consumers of alcohol. The diagnosis usually is based on a history of heavy alcohol use, findings from blood tests, and exclusion of other liver diseases by blood and imaging analyses. Liver biopsy specimens, usually collected via the transjugular route, should be analyzed to confirm a diagnosis of AH in patients with an atypical history or presentation. The optimal treatment for patients with severe AH is prednisolone, possibly in combination with N-acetyl cysteine. At present, only short-term increases in survival can be expected-no treatment has been found to increase patient survival beyond 3 months. Abstinence is essential for long-term survival. New treatment options, including liver transplantation, are being tested in trials and results eagerly are awaited.
Copyright © 2016 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcoholism; Cirrhosis; NAC; Steroid

Mesh:

Substances:

Year:  2016        PMID: 26948886      PMCID: PMC5828019          DOI: 10.1053/j.gastro.2016.02.074

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  74 in total

Review 1.  Alcoholic hepatitis.

Authors:  Michael R Lucey; Philippe Mathurin; Timothy R Morgan
Journal:  N Engl J Med       Date:  2009-06-25       Impact factor: 91.245

Review 2.  Pharmacotherapy for alcoholic patients with alcoholic liver disease.

Authors:  Cynthia L Vuittonet; Michael Halse; Lorenzo Leggio; Samuel B Fricchione; Michael Brickley; Carolina L Haass-Koffler; Tonya Tavares; Robert M Swift; George A Kenna
Journal:  Am J Health Syst Pharm       Date:  2014-08-01       Impact factor: 2.637

3.  Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.

Authors:  H P Porter; F R Simon; C E Pope; W Volwiler; L F Fenster
Journal:  N Engl J Med       Date:  1971-06-17       Impact factor: 91.245

4.  A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis.

Authors:  J Fehér; A Cornides; A Romány; M Kárteszi; L Szalay; A Gógl; J Picazo
Journal:  J Hepatol       Date:  1987-10       Impact factor: 25.083

5.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

6.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

7.  Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.

Authors:  Virendra Singh; Arun K Sharma; R Lakshmi Narasimhan; Ashish Bhalla; Navneet Sharma; Ratiram Sharma
Journal:  Am J Gastroenterol       Date:  2014-06-17       Impact factor: 10.864

8.  Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial.

Authors:  J C Trinchet; M Beaugrand; P Callard; D J Hartmann; C Gotheil; B V Nusgens; C M Lapiere; J P Ferrier
Journal:  Gastroenterol Clin Biol       Date:  1989-06

Review 9.  Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.

Authors:  Siddharth Singh; Mohammad Hassan Murad; Apoorva K Chandar; Connie M Bongiorno; Ashwani K Singal; Stephen R Atkinson; Mark R Thursz; Rohit Loomba; Vijay H Shah
Journal:  Gastroenterology       Date:  2015-06-16       Impact factor: 22.682

10.  White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers.

Authors:  Timothy Hardy; Christopher Wells; Stuart Kendrick; Mark Hudson; Christopher P Day; Alastair D Burt; Steven Masson; Stephen F Stewart
Journal:  BMC Gastroenterol       Date:  2013-03-26       Impact factor: 3.067

View more
  20 in total

Review 1.  Impact of etiological treatment on prognosis.

Authors:  Chien-Wei Su; Ying-Ying Yang; Han-Chieh Lin
Journal:  Hepatol Int       Date:  2017-07-12       Impact factor: 6.047

2.  Treatment of Alcoholic Liver Disease.

Authors:  Timothy R Morgan
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

3.  Pyroptosis, A novel player for alcoholic hepatitis?

Authors:  Shaogui Wang; Hua Wang; Wen-Xing Ding
Journal:  Hepatology       Date:  2018-03-26       Impact factor: 17.425

4.  Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.

Authors:  Arun J Sanyal; Philippe Mathurin; Laura A Nagy
Journal:  Gastroenterology       Date:  2016-05-04       Impact factor: 22.682

5.  A small RNA in neutrophils protects against acute-on-chronic alcoholic liver injury.

Authors:  Shaogui Wang; Wen-Xing Ding
Journal:  Gut       Date:  2016-10-08       Impact factor: 23.059

6.  Meta-analysis of patient survival and rate of alcohol relapse in liver-transplanted patients for acute alcoholic hepatitis.

Authors:  Mohammed Al-Saeedi; Muhammed H Barout; Pascal Probst; Elias Khajeh; Karl Heinz Weiss; Markus K Diener; Arianeb Mehrabi
Journal:  Langenbecks Arch Surg       Date:  2018-10-22       Impact factor: 3.445

7.  N-Acetyl Cysteine Treatment Restores Early Phase Fracture Healing in Ethanol-Fed Rats.

Authors:  Michael J Duryee; Anand Dusad; Carlos D Hunter; Kusum K Kharbanda; Joseph D Bruenjes; Karen C Easterling; Justin C Siebler; Geoffrey M Thiele; Dennis A Chakkalakal
Journal:  Alcohol Clin Exp Res       Date:  2018-05-27       Impact factor: 3.455

Review 8.  Interleukin-22 in alcoholic hepatitis and beyond.

Authors:  Xiaogang Xiang; Seonghwan Hwang; Dechun Feng; Vijay H Shah; Bin Gao
Journal:  Hepatol Int       Date:  2020-09-05       Impact factor: 6.047

Review 9.  [Hepatic steatosis : Differential diagnostics and current aspects].

Authors:  A Canbay; G Gerken; L P Bechmann
Journal:  Internist (Berl)       Date:  2016-09       Impact factor: 0.743

Review 10.  Transplantation for Alcohol-related Liver Disease: Is It Fair?

Authors:  Jessica L Mellinger; Michael L Volk
Journal:  Alcohol Alcohol       Date:  2018-03-01       Impact factor: 2.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.